—CMC
— • —
$70.33
P/E
15.80
PEG
—
FCF Yield
—
Rev Growth YoY
+838.0% YoY
Gross Margin
1774.0%
Health Score
6/10
D/E Ratio
0.32
Confidence
—
Business Snapshot
The company operates within an undisclosed sector and industry, making a precise competitive assessment difficult based on available data. It appears to be a financially stable entity with a healthy balance sheet, evidenced by a debt/equity ratio of 0.32x and a current ratio of 2.78x, suggesting low leverage and strong short-term liquidity. Net margin stands at 6.0%, indicating moderate profitability, while return on equity reaches 11.9%, reflecting adequate capital efficiency. However, the lack of revenue, market capitalisation, and segment data limits the ability to gauge its market position, scale, or competitive moat.
Financial Health
A net margin of 6.0% indicates modest profitability, but the gross margin figure (1774.0%) is flagged as outside a plausible range and cannot be relied upon. The debt/equity ratio of 0.32x is conservative, and the current ratio of 2.78x signals ample liquidity to cover short-term obligations...
Risk Assessment
- EARNINGS QUALITY — Only 1 of the last 4 quarters beat estimates (25%), indicating low earnings predictability and potential guidance credibility issues.
- DATA QUALITY — Revenue growth (838.0%) and earnings growth (63,858.0%) are flagged as outside plausible ranges, undermining the reliability of key fundamental metrics.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- FCF / CASH BURN — Free cash flow is not reported, leaving a critical component of financial health unobservable and limiting the assessment of cash generation....
Metric deep-dives